Antisense Therapeutics has begun the tenure of James Garner as their new Chief Executive Officer and Managing Director.
The company announced that Garner’s role as CEO commenced on August 7, 2023.
Antisense Therapeutics is a leading company focusing on pharmaceutical drug discovery and development.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
